Literature DB >> 20155460

Isolation and identification of cancer stem cells from human osteosarcom by serum-free three-dimensional culture combined with anticancer drugs.

Song Zhou1, Feng Li, Jun Xiao, Wei Xiong, Zhong Fang, Wenjian Chen, Pengyan Niu.   

Abstract

The cancer stem cells (CSCs) from human osteosarcoma by serum-free three-dimensional culture combined with anticancer drugs were isolated and identified. The primary cells derived from human osteosarcoma were digested by trypsin to prepare a single-cell suspension, and mixed homogeneously into 1.2% alginate gel. Single-cell alginate gel was cultured with serum-free DMEM/F12 medium. Epirubicin (0.8 microg/mL) was added to the medium to enrich CSCs. After cultured conventionally for 7 to 10 days, most of cells suspended in alginate gel were killed by epirubicin. But few cells survived and some single-cell cloning spheres formed. Immunofluorescent staining for Oct3/4 and Nanog was implemented to find cells with properties of self-renewal and multi-potential differentiation. Cells from cloning spheres were transplanted into BALB/c mice to detect the tumorigenicity in vivo. The results showed that some cells positive for Oct3/4 (TRITC) and Nanog (TRITC) were found in single-cell cloning spheres, and most of positive cells were concentrated in the core of sphere. Cells from spheres could form osteosarcoma in the body of mice. It was concluded that cells from single-cell cloning spheres had the properties of the expression of parts of stem cell genes (Oct3/4 and Nanog), resisting anti-cancer drugs, and tumorigenicity in vivo. To sum up, it is believed that cells obtained from osteosarcoma by serum-free three-dimensional culture combined with anticancer drugs are cancer stem cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20155460     DOI: 10.1007/s11596-010-0114-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  28 in total

1.  Long-term maintenance of brain tumor stem cell properties under at non-adherent and adherent culture conditions.

Authors:  Akihito Inagaki; Akio Soeda; Naoki Oka; Hideomi Kitajima; Jiro Nakagawa; Tsutomu Motohashi; Takahiro Kunisada; Toru Iwama
Journal:  Biochem Biophys Res Commun       Date:  2007-07-18       Impact factor: 3.575

2.  Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads.

Authors:  Julia F Markusen; Christopher Mason; Dearbhla A Hull; Martin A Town; Alethea B Tabor; Mark Clements; Christopher H Boshoff; Peter Dunnill
Journal:  Tissue Eng       Date:  2006-04

Review 3.  Alginate-based microcapsules for immunoisolation of pancreatic islets.

Authors:  Paul de Vos; Marijke M Faas; Berit Strand; Ricardo Calafiore
Journal:  Biomaterials       Date:  2006-08-01       Impact factor: 12.479

4.  Identification of bronchioalveolar stem cells in normal lung and lung cancer.

Authors:  Carla F Bender Kim; Erica L Jackson; Amber E Woolfenden; Sharon Lawrence; Imran Babar; Sinae Vogel; Denise Crowley; Roderick T Bronson; Tyler Jacks
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

5.  Physical properties of alginate hydrogels and their effects on in vitro follicle development.

Authors:  Erin R West; Min Xu; Teresa K Woodruff; Lonnie D Shea
Journal:  Biomaterials       Date:  2007-07-23       Impact factor: 12.479

6.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

7.  Childhood cancer survival trends in Europe: a EUROCARE Working Group study.

Authors:  Gemma Gatta; Riccardo Capocaccia; Charles Stiller; Peter Kaatsch; Franco Berrino; Monica Terenziani
Journal:  J Clin Oncol       Date:  2005-06-01       Impact factor: 44.544

8.  Isolation of cancer stem cells from adult glioblastoma multiforme.

Authors:  Xiangpeng Yuan; James Curtin; Yizhi Xiong; Gentao Liu; Sebastian Waschsmann-Hogiu; Daniel L Farkas; Keith L Black; John S Yu
Journal:  Oncogene       Date:  2004-12-16       Impact factor: 9.867

9.  Engineering tumors with 3D scaffolds.

Authors:  Claudia Fischbach; Ruth Chen; Takuya Matsumoto; Tobias Schmelzle; Joan S Brugge; Peter J Polverini; David J Mooney
Journal:  Nat Methods       Date:  2007-09-02       Impact factor: 28.547

10.  Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types.

Authors:  Jens M Kelm; Nicholas E Timmins; Catherine J Brown; Martin Fussenegger; Lars K Nielsen
Journal:  Biotechnol Bioeng       Date:  2003-07-20       Impact factor: 4.530

View more
  3 in total

1.  Treatment of agarose-agarose RENCA macrobeads with docetaxel selects for OCT4(+) cells with tumor-initiating capability.

Authors:  Lawrence S Gazda; Prithy C Martis; Melissa A Laramore; Melissa A Bautista; Atira Dudley; Horatiu V Vinerean; Barry H Smith
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

2.  Osteosarcoma cells differentiate into phenotypes from all three dermal layers.

Authors:  Scott Russinoff; Sara Miran; Ashok L Gowda; Paul A Lucas
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

3.  Implication of expression of Nanog in prostate cancer cells and their stem cells.

Authors:  Chen Gong; Hui Liao; Fengjin Guo; Liang Qin; Jun Qi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-04-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.